• Asthma/COPD

Asthma/COPD:

Indications for PROAIR HFA:

Bronchospasm.

Adults and Children:

<4yrs: not established. ≥4yrs: 2 inh every 4–6hrs; in some patients: 1 inh every 4hrs may suffice. Exercise-induced bronchospasm: 2 inh 15–30mins before exercise.

Warnings/Precautions:

Avoid excessive use. Sensitivity to sympathomimetics. Discontinue if paradoxical bronchospasm or cardiovascular effects occur. Cardiovascular disorders (eg, coronary insufficiency, arrhythmias, hypertension). Diabetes. Hyperthyroidism. Seizure disorders. Reevaluate periodically. Elderly. Labor & delivery. Pregnancy. Nursing mothers: not recommended.

Pharmacologic Class:

Beta-2 agonist.

Interactions:

During or within 2 weeks of MAOIs or tricyclics (increased cardiovascular effects); consider alternative therapy. Oral sympathomimetics: not recommended. Antagonized by β-blockers. Monitor digoxin. Caution with non-potassium sparing diuretics (eg, loop or thiazide); monitor.

Adverse Reactions:

Headache, tachycardia, pain, dizziness, pharyngitis, rhinitis; hypokalemia, paradoxical bronchospasm, cardiovascular effects, immediate hypersensitivity reactions (eg, rash, urticaria, angioedema).

How Supplied:

Inhalation aerosol (w. dose counter)—8.5g (200 inh)